Brief report
Usefulness of echocardiographic determined tricuspid regurgitation in predicting event-free survival in severe heart failure secondary to idiopathic-dilated cardiomyopathy or to ischemic cardiomyopathy

https://doi.org/10.1016/S0002-9149(98)00624-9Get rights and content

Abstract

In summary, we reviewed 2-dimensional and color Doppler echocardiographic data from 117 patients with advanced symptomatic heart failure to determine if echocardiographic TR would predict RV function and event-free survival. The presence of echocardiographic TR predicted RV dilation and dysfunction and was associated with worse survival.

Cited by (125)

  • Transcatheter tricuspid valve interventions: Current devices and associated evidence

    2021, Progress in Cardiovascular Diseases
    Citation Excerpt :

    Historically, TR was considered as a mere consequence of the primary -left heart- disease without specific focus on its management.3 However, the understanding of both the progressive nature of isolated or secondary TR (despite treatment of the primary disease) and its deleterious impact on prognosis have led to a growing concern in the past decades.4–7 While medical therapy may improve TR symptoms, it does not prevent the progressive adverse remodelling of the right-sided heart; tricuspid valve (TV) repair or replacement may therefore be needed to control the progression of RV dysfunction and long lasting heart failure (HF).8–10

  • Natural Course of Nonsevere Secondary Tricuspid Regurgitation

    2021, Journal of the American Society of Echocardiography
View all citing articles on Scopus
1

Dr. Di Salvo's address is: MGH Heart Failure Center, Bigelow 628, Massachusetts General Hospital, 55 Fruit St, Boston, Massachusetts 02114.

View full text